Target intelligence / Profile preview

Transcriptional program of bronchial epithelial differentiation

Molecular classification
Other, Biological Process, Transcription factor
01

Overview

The transcriptional program of bronchial epithelial differentiation is a complex biological process rather than a single molecular target. it involves a coordinated network of transcription factors, including NKX2-1, SOX2, and FOXA1/2, which direct the maturation of basal progenitor cells into specialized ciliated, secretory (goblet and club), and neuroendocrine cells (Morrisey & Hogan, 2010). This program is tightly regulated by evolutionary conserved signaling pathways such as Notch, which acts as a binary switch between ciliated and secretory lineages (Rock et al., 2011). In chronic respiratory diseases like COPD and asthma, this program is pathologically altered, leading to goblet cell hyperplasia and a reduction in functional ciliated cells, which impairs mucus clearance (Crystal et al., 2008). While the program itself is not a classical drug target, therapeutic interventions often focus on modulating its components—such as Notch signaling or retinoic acid receptors—to reverse airway remodeling. Understanding this differentiation program is essential for developing regenerative therapies aimed at restoring healthy lung epithelium in patients with chronic obstructive or inflammatory airway diseases.

Other names
Airway epithelial differentiation programMucociliary differentiationBronchial epithelial cell fate determinationRespiratory epithelial transcriptional network
02

Mechanism of action

Modulation of signaling pathways such as Notch, Wnt, and BMP, or activation of nuclear receptors to influence the fate of basal progenitor cells and restore the balance of ciliated and secretory cell populations.

03

Biological functions

Cell differentiationTissue homeostasisCiliogenesisMucus secretionCell proliferation
04

Disease associations

Chronic Obstructive Pulmonary Disease (COPD)AsthmaCystic FibrosisLung CancerBronchitis
05

Safety considerations

Risk of squamous metaplasiaImpaired mucociliary clearancePotential for oncogenic transformationDisruption of innate immune barriers
06

Interacting drugs

Tretinoin

3 more in the full profile.

07

Biomarkers

FOXJ1MUC5ACSCGB1A1KRT5TP63NKX2-1

Beyond the preview

Go deeper on Transcriptional program of bronchial epithelial differentiation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcriptional program of bronchial epithelial differentiation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call